HDR Brachytherapy for Superficial Non‐Melanoma Skin Cancers

Key Points

Key points are not available for this paper at this time.

Abstract

Delivering 36 Gy over 2 weeks to superficial NMSC using HDR brachytherapy is well tolerated and provides a high local control rate without significant toxicity.

Mark Helpful

Bookmark

Relay

Mark Helpful

Bookmark

Relay

Cite This Study

Gauden et al. (Mon,) studied this question.

synapsesocial.com/papers/69da96a30f32475823a3d6a5 https://doi.org/https://doi.org/10.1111/j.1754-9485.2012.02466.x

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The GEC ESTRO handbook of brachytherapy2002 · 327 citations
2HDR brachytherapy for the treatment of skin cancers using standard surface applicators2008 · 9 citations
3External irradiation of epithelial skin cancer1990 · 214 citations
4Design and evaluation of a HDR skin applicator with flattening filter2008 · 58 citations
5Treatment of skin carcinomas using CT-assisted 3D high-dose-rate brachytherapy and custom made surface molds2008 · 1 citations